Multiplex image-based autophagy RNAi screening identifies SMCR8 as ULK1 kinase activity and gene expression regulator

  1. Jennifer Jung
  2. Arnab Nayak
  3. Véronique Schaeffer
  4. Tatjana Starzetz
  5. Achim Klaus Kirsch
  6. Stefan Müller
  7. Ivan Dikic
  8. Michel Mittelbronn
  9. Christian Behrends  Is a corresponding author
  1. Goethe University School of Medicine, Germany
  2. Goethe University, Germany
  3. PerkinElmer, Inc., Germany

Abstract

Autophagy is an intracellular recycling and degradation pathway that depends on membrane trafficking. Rab GTPases are central for autophagy but their regulation especially through the activity of Rab GEFs remains largely elusive. We employed a RNAi screen simultaneously monitoring different populations of autophagosomes and identified 34 out of 186 Rab GTPase, GAP and GEF family members as potential autophagy regulators, amongst them SMCR8. SMCR8 uses overlapping binding regions to associate with C9ORF72 or with a C9ORF72-ULK1 kinase complex holo-assembly, which function in maturation and formation of autophagosomes, respectively. While focusing on the role of SMCR8 during autophagy initiation, we found that kinase activity and gene expression of ULK1 are increased upon SMCR8 depletion. The latter phenotype involved association of SMCR8 with the ULK1 gene locus. Global mRNA expression analysis revealed that SMCR8 regulates transcription of several other autophagy genes including WIPI2. Collectively, we established SMCR8 as multifaceted negative autophagy regulator.

Article and author information

Author details

  1. Jennifer Jung

    Institute of Biochemistry II, Goethe University School of Medicine, Frankfurt, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9436-4021
  2. Arnab Nayak

    Institute of Biochemistry II, Goethe University School of Medicine, Frankfurt, Germany
    Competing interests
    No competing interests declared.
  3. Véronique Schaeffer

    Institute of Biochemistry II, Goethe University School of Medicine, Frankfurt, Germany
    Competing interests
    No competing interests declared.
  4. Tatjana Starzetz

    Neurological Institute, Goethe University, Frankfurt, Germany
    Competing interests
    No competing interests declared.
  5. Achim Klaus Kirsch

    PerkinElmer, Inc., Hamburg, Germany
    Competing interests
    No competing interests declared.
  6. Stefan Müller

    Institute of Biochemistry II, Goethe University School of Medicine, Frankfurt, Germany
    Competing interests
    No competing interests declared.
  7. Ivan Dikic

    Institute of Biochemistry II, Goethe University School of Medicine, Frankfurt, Germany
    Competing interests
    Ivan Dikic, Senior Editor eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8156-9511
  8. Michel Mittelbronn

    Neurological Institute, Goethe University, Frankfurt, Germany
    Competing interests
    No competing interests declared.
  9. Christian Behrends

    Institute of Biochemistry II, Goethe University School of Medicine, Frankfurt, Germany
    For correspondence
    behrends@em.uni-frankfurt.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9184-7607

Funding

Deutsche Forschungsgemeinschaft (SFB1177)

  • Stefan Müller
  • Ivan Dikic
  • Christian Behrends

Munich Cluster of Systems Neurology (EXC 1010 SyNergy)

  • Christian Behrends

Goethe-Universität Frankfurt am Main (EXC115)

  • Ivan Dikic

LOEWE Zentrum (Ub-net)

  • Stefan Müller
  • Ivan Dikic
  • Christian Behrends

European Research Council (ERC,282333-XABA)

  • Christian Behrends

Deutsche Forschungsgemeinschaft (DI 931/3-1)

  • Ivan Dikic

LOEWE Zentrum (Gene and Cell Therapy Frankfurt)

  • Christian Behrends

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Jung et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,857
    views
  • 915
    downloads
  • 71
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jennifer Jung
  2. Arnab Nayak
  3. Véronique Schaeffer
  4. Tatjana Starzetz
  5. Achim Klaus Kirsch
  6. Stefan Müller
  7. Ivan Dikic
  8. Michel Mittelbronn
  9. Christian Behrends
(2017)
Multiplex image-based autophagy RNAi screening identifies SMCR8 as ULK1 kinase activity and gene expression regulator
eLife 6:e23063.
https://doi.org/10.7554/eLife.23063

Share this article

https://doi.org/10.7554/eLife.23063

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Joar Esteban Pinto Torres, Mathieu Claes ... Yann G-J Sterckx
    Research Article

    African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.

    1. Biochemistry and Chemical Biology
    Jianheng Fox Liu, Ben R Hawley ... Samie R Jaffrey
    Tools and Resources

    N 6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene-level annotations cannot capture the diversity of m6Am modification in the transcriptome. Here, we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription.